Epidermolysis Bullosa: Developing Drugs for Treatment of Cutaneous Manifestations; Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 28, 2019
October 25, 2019
3a5ca8cb-694b-49c7-9a78-110c0ad383ca
Related Documents
Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention Guidance for Industry
Guidance DocumentJuly 29, 2019Center for Drug Evaluation and Research
Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentSeptember 24, 2019Center for Drug Evaluation and Research
Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox